RELENZA, an influenza neuraminidase inhibitor, is
of influenza in patients 7 years of age and older who
have been symptomatic for no more than 2 days.
(1.1)Prophylaxis of influenza in patients 5 years of age and older.
(1.2)Important Limitations on Use of RELENZA:Not recommended
for treatment or prophylaxis of influenza in:Individuals with underlying airways disease.
(5.1)Not proven effective for:Treatment in individuals with underlying airways
(1.3)Prophylaxis in nursing home residents.
(1.3)Not a substitute for annual
-- acute viral infection involving the respiratory tract; marked by inflammation of the nasal mucosa, the pharynx, and conjunctiva, and by headache and severe, often generalized, myalgia.
Do not use in patients with history of allergic
reaction to any ingredient of RELENZA including lactose (which contains
milk proteins) [see Warnings and Precautions
(5.2), Description (11)].
-- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor.
It should not to be used for self-diagnosis or treatment.